Biome Analytics Company Profile

Background

Founded in 2013 and headquartered in San Francisco, California, Biome Analytics is a healthcare technology company specializing in cardiovascular performance improvement solutions. The company's mission is to assist cardiovascular clinicians and health systems in delivering optimal care to the maximum number of patients at the lowest possible cost. Biome Analytics achieves this by leveraging advanced data analytics, machine learning, and artificial intelligence to transform healthcare delivery, enhance patient outcomes, and reduce costs.

Key Strategic Focus

Biome Analytics concentrates on providing clinical performance solutions that enable healthcare providers to deliver superior cardiovascular care efficiently. The company's core objectives include:

Performance Network: A suite of machine learning-driven applications that identify high-impact performance improvement opportunities, offering precise insights into practices, processes, and population cohorts affecting clinical and financial outcomes.

Opportunity Engine™: This solution utilizes advanced machine learning to automatically identify and prioritize clinical and financial performance opportunities with the greatest impact on outcomes.

Risk Audit: An AI-powered documentation audit product designed to enhance cardiovascular data accuracy and revenue optimization by integrating quality data and billing information.

Financials and Funding

As of October 2024, Biome Analytics reported annual revenues of approximately $15 million. The company has raised a total of $609,000 in funding, with the most recent round occurring in February 2020.

Technological Platform and Innovation

Biome Analytics distinguishes itself through its proprietary technologies and innovative methodologies:

Machine Learning and AI: The company employs advanced machine learning algorithms and artificial intelligence to analyze complex cardiovascular data, enabling precise identification of performance improvement opportunities.

Data Integration: By integrating traditionally siloed quality data and billing information, Biome's solutions enhance documentation accuracy and revenue optimization.

Leadership Team

Biome Analytics is led by a team of experienced professionals:

Stuart Jacobson: Chief Executive Officer and Chairman.

Rakan Khaki, MPH: Chief Operating Officer.

Skye Lawrence: Chief Product Officer.

Seth Glickman: Chief Technology Officer.

Jeff Luck, MBA, PhD: Chief Scientist.

Amber Pawlikowski, RN, MSN, CPHQ: Vice President of Performance Improvement.

Matthew Esham: Vice President of Analytics.

Khalid Latif, PhD: Vice President of Research and Development.

Brian Maher, MPH: Vice President of Business Development.

Leadership Changes

In February 2023, Biome Analytics announced the promotions of Matthew Esham to Vice President of Analytics and Amber Pawlikowski to Vice President of Performance Improvement. Additionally, Elsa Mersereau joined the company as a Performance Improvement Consultant.

Competitor Profile

Market Insights and Dynamics

The healthcare analytics market is experiencing significant growth, driven by the increasing need for data-driven decision-making in healthcare to improve patient outcomes and reduce costs. The cardiovascular segment, in particular, presents substantial opportunities for performance improvement solutions.

Competitor Analysis

Key competitors in the healthcare analytics space include:

AlphaSense: Focuses on providing market intelligence and search capabilities for financial services.

Dataiku: Offers a data science platform that enables organizations to build and deploy their own data products.

LUMEDX: Specializes in cardiovascular information systems and data analytics solutions.

Kensho Technologies: Provides analytics and machine learning solutions for financial services.

Sentieo: Delivers financial research and analytics tools.

Biome Analytics differentiates itself by focusing specifically on cardiovascular performance improvement, leveraging proprietary machine learning and AI technologies to deliver actionable insights tailored to cardiovascular care.

Strategic Collaborations and Partnerships

Biome Analytics has established significant partnerships to enhance its offerings:

Ascend.io: In June 2023, Biome partnered with Ascend.io to utilize data pipeline automation technology, enabling the company to process three times more data and deliver insights more frequently to clients.

Barnes-Jewish Hospital: Collaborated to improve clinical outcomes for cardiovascular patients, achieving top-decile performance in observed-to-expected ratios for bleeding events and significant cost reductions per avoidable complication during percutaneous coronary interventions.

Operational Insights

Biome Analytics' strategic focus on cardiovascular performance improvement, combined with its proprietary technologies and strategic partnerships, positions the company as a leader in the healthcare analytics market. Its ability to deliver actionable insights and measurable outcomes provides a distinct competitive advantage.

Strategic Opportunities and Future Directions

Looking ahead, Biome Analytics aims to expand its suite of AI-powered solutions, further integrate data sources to enhance analytics capabilities, and strengthen partnerships with healthcare providers to drive continuous improvement in cardiovascular care. The company's commitment to innovation and excellence positions it well to capitalize on emerging opportunities in the healthcare analytics landscape.